Its glucose-lowering is well characterized across the SURPASS trials and confirmed in real-world use
Other Double Agonists and Triple Agonist Beyond tirzepatide, pharmaceutical companies have developed additional dual receptor agonists targeting GLP-1 and glucagon (GCG) as well as triple receptor agonists.210 Mazdutide represents the most recent advancement in GLP-1/GCG dual receptor agonists;211213 this agent, co-developed by Cinda Biology and Lilly Pharmaceutical, received marketing approval in China on June 27, 2025
Legitimate retatrutide in lyophilized form should appear as a white to off-white powder
Some people prefer weekly injections to avoid daily medication routines, while others prefer daily pills to avoid needles
Diabetic retinopathy worsening Rapid improvements in blood glucose with GLP-1s can be linked to a temporary worsening of diabetic retinopathy in those with pre-existing advanced eye disease
86 complaints, bundle pricing traps, a no-refund-once-shipped policy, and a cancellation process that requires a phone call with retention scripts